In Profile: Dr Cormac Convery
Dr Cormac Convery shares his passion for clinical research and pioneering advanced treatments in rhinophyma Dr Cormac Convery is an aesthetic practitioner at the forefront of research and education in
Dr Cormac Convery shares his passion for clinical research and pioneering advanced treatments in rhinophyma Dr Cormac Convery is an aesthetic practitioner at the forefront of research and education in
Aesthetic device supplier 3D Aesthetics has released data from its latest clinical study on the 3D EMlift device. The device combines high intensity focused electromagnetic energy and radiofrequency, and is
Dr Emmaline Ashley explores the current literature surrounding the use of botulinum toxin in depression
Dr Raul Cetto conducts a literature review on the studies discussing environmental influences on cutaneous ageing and their clinical consequences
A study published in the Journal of Cosmetic Dermatology has introduced the Nose Pliability Assessment Scale (NPAS) to be conducted prior to non-surgical rhinoplasties.
A study published in Skin Health and Disease has revealed that of 655 respondents who were patients who recently received botulinum toxin treatment, 79% reported some form of adverse event.
A study published in The European Molecular Biology Organization Journal has shed new light on how botulinum toxin is able to infiltrate neurons in the brain.
A new clinical study has revealed the benefit of medical-grade, at-home topical skincare for treating discolouration on the skin.
In a new study published in Facial Plastic Surgery, it has been proposed that botulinum toxin can be used alongside septorhinoplasty procedures to help correct the appearance of a crooked nose.
Pharmaceutical company Galderma has released the results of its two phase III studies for its liquid formulation of botulinumtoxinA (relabotulinumtoxinA).